Adaptin Bio (APTN) Non Operating Income (2024 - 2026)

Adaptin Bio (APTN) has 3 years of Non Operating Income data on file, last reported at -$1943.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 100.79% year-over-year to -$1943.0; the trailing twelve-month figure through Mar 2026 stood at -$1943.0 (up 99.27% YoY), and the FY2025 full-year result was $247374.0, up 144.76% from the prior year.
• Non Operating Income eased to -$1943.0 in Q1 2026, from $247374.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $247374.0 in Q1 2025 to a low of -$348756.0 in Q4 2024.
• A 3-year average of -$51206.8 and a median of -$45557.0 in 2024 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income jumped 723.17% in 2025 and tumbled 100.79% in 2026, its largest moves.
• Tracing APTN's Non Operating Income over 3 years: stood at -$348756.0 in 2024, then jumped by 170.93% to $247374.0 in 2025, then sank by 100.79% to -$1943.0 in 2026.
• Business Quant data shows APTN's Non Operating Income at -$1943.0 in Q1 2026, $247374.0 in Q1 2025, and -$348756.0 in Q4 2024.